© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.